The Current Ratio as of November 2024 (TTM) for Adaptive Biotechnologies Corporation (ADPT) is 3.52

According to Adaptive Biotechnologies Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 3.52. This represents a change of -15.60% compared to the average of 4.17 of the last 4 quarters.

Adaptive Biotechnologies Corporation (ADPT) Historical Current Ratio (quarterly & annually)

How has ADPT Current Ratio performed in the past?

The mean historical Current Ratio of Adaptive Biotechnologies Corporation over the last ten years is 6.54. The current 3.52 Current Ratio has changed 5.28% with respect to the historical average. Over the past ten years (40 quarters), ADPT's Current Ratio was at its highest in in the September 2020 quarter at 8.70. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Adaptive Biotechnologies Corporation (ADPT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Adaptive Biotechnologies Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Adaptive Biotechnologies Corporation (ADPT) Average Current Ratio

How has ADPT Current Ratio performed in the past?

The current Current Ratio of Adaptive Biotechnologies Corporation (ADPT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Adaptive Biotechnologies Corporation (ADPT) Current Ratio vs. Peers

How is ADPT’s Current Ratio compared to its peers?

Adaptive Biotechnologies Corporation’s Current Ratio is less than Verve Therapeutics, Inc. (13.05), less than Beam Therapeutics Inc. (5.69), less than Caribou Biosciences, Inc. (7.38), less than Sana Biotechnology, Inc. (4.47), less than VectivBio Holding AG (9.14), less than Kinnate Biopharma Inc. (13.19), greater than Royalty Pharma plc (1.54), less than Ikena Oncology, Inc. (15.32), less than CohBar, Inc. (15.69), greater than Hepion Pharmaceuticals, Inc. (1.30), less than Rain Therapeutics Inc. (5.58), less than Krystal Biotech, Inc. (7.97), less than AVROBIO, Inc. (26.17), less than Enveric Biosciences, Inc. (5.17), less than Elevation Oncology, Inc. (17.77), less than Zura Bio Limited (10.36), less than Reneo Pharmaceuticals, Inc. (57.86), less than Legend Biotech Corporation (4.98), less than Vir Biotechnology, Inc. (8.94), less than Apellis Pharmaceuticals, Inc. (4.36),

Build a custom stock screener for Adaptive Biotechnologies Corporation (ADPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adaptive Biotechnologies Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adaptive Biotechnologies Corporation (ADPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adaptive Biotechnologies Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.